Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
RE ›
REMYNDER
Trademark search for:
REMYNDER
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-03-24 — Application filed
2011-03-28 — Application filed
2011-03-29 — Application filed
2011-06-02 — Assigned to examiner
2011-06-03 — Final disposition recorded
2011-06-03 — Final disposition recorded
2011-06-03 — Final disposition recorded
2011-07-18 — Office action issued
2011-07-18 — Correspondence received in law office
2011-07-19 — Teas/email correspondence entered
2011-07-20 — Approved for pub - principal register
2011-07-20 — Assigned to lie
2011-08-01 — Law office publication review completed
2011-09-06 — Published for opposition
2011-09-06 — Official gazette publication confirmation e-mailed
2011-11-01 — Noa e-mailed - sou required from applicant
2011-11-08 — Teas delete 1(b) basis received
2011-11-08 — Notice of allowance cancelled
2011-11-09 — Case assigned to intent to use paralegal
2011-11-09 — 1(b) basis deleted; proceed to registration
2012-01-24 — Registered-principal register
2017-01-24 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2018-08-31 — Cancelled sec. 8 (6-yr)
2018-08-31 — Final status recorded
Owner Information
Bayer Aktiengesellschaft
Leverkusen DE
Bayer Aktiengesellschaft
Leverkusen DE
Bayer Aktiengesellschaft
Leverkusen DE
Correspondent
WILLIAM F. LAWRENCE FROMMER LAWRENCE & HAUG LLP 745 5TH AVE NEW YORK, NY 10151-0099 UNITED STATES
Filing Details
Filing Date:
2011-03-24
Status Date:
2018-08-31
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.